Federal Register Notice: FDA’s Arthritis Advisory Committee will meet 11/24, from 8:30 a.m. to 4:30 p.m. at the Hilton Washington DC/Silver Spring, The Ballrooms, 8727 Colesville Rd., Silver Spring, MD. Contact Nicole Vesely, (301) 827-6793. The committee will discuss a Takeda Pharmaceuticals North America NDA for Uloric (febuxostat) for the proposed treatment of hyperuricemia in patients with gout. To view this notice, click here.
